February 2021 updates to the website
18 February 2021
The website has now been updated following February's LSCMMG
The following guidelines have been added/updated:
Rheumatoid Arthritis High Cost Drugs Pathway - Update
The following Items will be updated and added to the website following the Joint Committee of CCGs (JCCCG) Meeting:
Brolucizumab - For treating wet age-related macular degeneration (TA672)